Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Genesis of Pain in Migraine

Similar presentations


Presentation on theme: "The Genesis of Pain in Migraine"— Presentation transcript:

1 The Genesis of Pain in Migraine
Anna Andreou The Headache Centre Wolfson Centre, King’s College London & Guy’s & St Thomas's NHS Foundation Trust Headache Centre

2 Migraine – More Than a Pain Disorder
A clinical syndrome characterised by headache with specific features and associated symptoms Structural Functional Behavioural Environmental Nausea/Vomiting Sensory disturbances Poor Concertation Limited Activities Disability Craving Yawning Fluid retention Heighten Perception Hangover Anorexia Tired Diurisis Visual changes Speech difficulties Confusion Numbness Multifactorial predisposition Multifactorial predisposition Interictal Phase Premonitory Aura Headache Postdrome Interictal phase Adapted from Blau JN. Lancet 1992; 339: 1202–7

3 How is Migraine Headache Generated Following Hypothalamic Activation?
Other brain areas Hypothalamus Migraine pain pathways Premonitory phase Attack progression Migraine Headache

4 The Hypothalamus- A Brain in the Brain

5 Our Results: Migraine-Triggering Substances Change the Activity of the A11 Hypothalamic Nucleus Migraine-Triggering Substances in the A11 Hypothalamic Nucleus Facilitate the Migraine Pain Pathway Many hypothalamic chemicals change their activity during experimental induction of a migraine

6 …But We Remain Committed and
WE WILL SUCCEED Thank you for all your support!

7 Guy’s and St Thomas’ NHS Trust & King’s College London
How does Single Pulse Transcranial Magnetic Stimulation (sTMS) Prevent Migraine? Joseph Lloyd Headache Research Lab The Headache Centre Guy’s and St Thomas’ NHS Trust & King’s College London

8 sTMS in the Acute and Preventive Treatment of Migraine
? Underlying Mechanism of Action in the Treatment of Acute Migraine ? Acute Treatment Lipton et al. Lancet Neurol,2010; 9(4): Preventive Treatment Bhola et al., JHP 2015;16:535 Starling et al., Cephalalgia 2018, Vol. 38(6) 1038–1048

9 GSTT data Demographic and clinical characteristics at baseline of 42 migraine patients treated with sTMS Sex, M/F 5/37 Age (y), mean ± SD 43 ± 19 Aura, N (%) 11 (26.2%) Chronic migraine/High frequency episodic migraine 37/5 Failed Botox, N (%) 20 (47.6) Headache days 14.7 Migraine days 11.1 HIT-6 63.3 MTIS

10 ? Underlying Mechanism of Action in the Treatment of Acute Migraine ?
Non –Invasive Single Pulse Transcranial Magnetic Stimulation – A Cortical Treatment for Migraine ? Underlying Mechanism of Action in the Treatment of Acute Migraine ? The long history of developing a portable sTMS device Future

11 sTMS Mechanism of Action in Migraine
? Underlying Mechanism of Action in the Treatment of Acute Migraine ? 11 mm rodent sTMS coil Andreou et al, Brain, 2016; 139(7): 2002–2014

12 sTMS can influence hypothalamic activity in A11 dopaminergic nucleus
Our Results: sTMS can influence hypothalamic activity in A11 dopaminergic nucleus sTMS effect on hypothalamic activity is consistent and cumulative

13 London Marathon 2018 Total of £17,450 raised Massive thank you!


Download ppt "The Genesis of Pain in Migraine"

Similar presentations


Ads by Google